Revenue segments as reported by the company.

Premiums

Products

Services

Investment and other income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Medical costs

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

UnitedHealth Group

Optum is a Health Services platform. It is a leading information and technology-enabled health services business dedicated to modernizing the system and improving the health of people and communities.

Optum

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

UnitedHealth Group reports strong Q4 earnings and growth opportunities

UnitedHealth Group's Q4 2022 Earnings Call highlighted strong financial performance, growth initiatives, and confidence in sustainable earnings growth. The company is focused on enhancing consumer experiences, expanding value-based care, and driving growth through strategic investments and M&A priorities. Challenges include managing cost impacts from flu and respiratory issues, while opportunities lie in continued growth in key segments and strategic M&A.

UnitedHealth Group reports robust Q1 earnings, eyes growth opportunities

UnitedHealth Group's strong performance in Q1 2023 reflects growth across its segments, driven by a focus on value-based care and consumer-centric initiatives. While challenges exist with potential Medicare Advantage model changes, the company remains optimistic about sustained growth and opportunities for expansion.

UnitedHealth Group posts robust Q2 earnings, eyes tech-driven growth

UnitedHealth Group delivered strong financial performance in Q2 2023, with a focus on expanding patient care, driving cost efficiencies, and responding to changing healthcare dynamics. Challenges include margin pressures and managing investment gains unpredictability. Opportunities lie in leveraging technology for cost reduction and enhancing care capabilities post acquisitions.

UnitedHealth Group reports robust Q3 growth, eyes expansion in value-based care

UnitedHealth Group's Q3 performance showcased robust revenue growth and strengthened earnings outlook. The company's focus on value-based care, strong performance in pharmacy services, and investments in home care present opportunities for future growth. However, challenges related to wage inflation and margin impact at Optum Health require attention.

UnitedHealth Group posts strong 2023 results, eyes growth opportunities

UnitedHealth Group's 2023 performance showcased robust financial results, strategic investments in digital engagement, and a focus on improving healthcare quality and accessibility. While facing challenges in cost trends and industry dynamics, the company remains optimistic about its competitive positioning and growth prospects in 2024.

UnitedHealth Group resilient post-cyberattack, eyes growth opportunities

UnitedHealth Group navigated cyberattack impacts while maintaining outlook.
Strong response to challenges, focusing on growth and customer support.
Balanced approach to capital deployment and confidence in future opportunities.
Optimism in controlling costs and driving growth through innovation.

UnitedHealth Group reports resilient growth amidst cyberattack challenges

UnitedHealth Group's Q2 2024 performance reflects resilience and growth potential despite challenges from a cyberattack and other disruptions.
The company's strengths in customer recognition, Medicare Advantage programs, and technology innovation position it well for future success and market expansion.
While facing challenges like cyberattack impacts and medical care ratio issues, UnitedHealth Group remains focused on opportunities for growth and returning to baseline performance in 2025.

UnitedHealth Group affirms growth outlook amidst challenges, eyes 2025 strategy

UnitedHealth Group's Q3 2024 performance reflects strong revenue growth and a commitment to value-based care and innovation. Despite challenges like cyberattacks and care patterns impacting earnings outlook, the company remains focused on long-term growth objectives. UNH's strategic investments, focus on consumer experience, and capital deployment priorities signal a proactive approach to driving future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS Health

Humana

Shares of U.S. health insurers dropped between 4% and 9% premarket on Tuesday after reimbursement rates to providers of Medicare Advantage health plans were unchanged from the initial proposal, raising worries about a squeeze on margins next year.

US health insurers slide as final Medicare Advantage rate sparks margin hit fears

Apple

Boeing

Intel

NIKE

CNBC's Jim Cramer on Monday analyzed the five stocks that performed the worst on Dow Jones Industrial Average during the first quarter.

Jim Cramer reviews the Dow's five worst performers during the first quarter

The latest trading day saw UnitedHealth Group (UNH) settling at $489.70, representing a -1.01% change from its previous close.

UnitedHealth Group (UNH) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Centene

Elevance Health Inc

Molina Healthcare

UnitedHealth, Humana and other big health insurers fell Monday night on lower-than-expected Medicare Advantage rates for 2025.

UnitedHealth, Health Insurers Tumble On Medicare Advantage Rates

Coca-Cola European Partners plc

CRH PLC

Domino's Pizza

Global Payments

Mastercard

Monolithic Power Systems

MSCI

Rollins

Ross Stores

Sirius XM Holdings Inc

Visa

Zoetis

The SPDR S&P 500 ETF Trust had a 3.27% return in March, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares. The top 15 dividend growth stocks for April 2024 offer an average dividend yield of 1.44% and appear to be about 24% undervalued based on dividend yield theory.

My Top 15 High Growth Dividend Stocks For April 2024

Fitch does not anticipate any credit impact on not-for-profit hospitals in the United States from the cyberattack at UnitedHealth's tech unit Change Healthcare that caused disruption to pharmacies across the U.S., the ratings agency said on Monday.

Fitch says UnitedHealth unit hack to have no credit impact on not-for-profit hospitals

UnitedHealth (UNH) unit Optum's acquisition of Steward Health's physician group is expected to close in the second quarter of 2024.

UnitedHealth's (UNH) Optum to Buy Steward's Physician Group

AbbVie

HCA Healthcare

Intuitive Surgical

Eli Lilly

Novo Nordisk

Vertex Pharmaceuticals

These seven healthcare companies are industry and market leaders. They generally present excellent long-term prospects, too.

Meet The "Magnificent Seven" of Healthcare Stocks

Abbott Labs

Merck

As the number of grey-haired people rises worldwide, investors need to notice the strong-buy  healthcare stocks. The need for healthcare will grow as the number of people aged 60 years and older doubles by 2050, a situation never before witnessed in the world, thanks to smaller families and longer lifespans.

3 Strong Buy Healthcare Stocks to Add to Your Q2 Must-Watch List

STMicroelectronics NV ADR RegS

Ulta Beauty

While investors chase overhyped momentum plays, smart money looks elsewhere for overlooked bargains. This article cuts through the noise, identifying undervalued, under-the-radar stocks to buy and hold using a discounted cash flow and earnings approach.

3 Under-the-Radar Stocks to Buy and Hold for the Long Term

Last month, a hacker group known as ALPHV BlackCat attacked the U.S. healthcare system. Now, the federal government is offering a $10 million reward to help identify the people behind the organization.

US Pledges $10 Million Reward in Hunt for UnitedHealth Hackers

Barron's published an article in February discussing cheap healthcare stocks to buy, noting comments from Janus Henderson Global Life Sciences (MUTF: JAGLX ) co-manager Andy Acker. “At one point in October [2023], we had 232 biotech companies trading below the levels of cash on their balance sheet,” Acker told Barron's.

3 Healthcare Stocks to Buy From 3 of the Best Actively Managed Funds

UnitedHealth Group said on Wednesday that it had advanced more than $3.3 billion so far to care providers impacted by the Change Healthcare cyberattacks.

UnitedHealth Group has paid over $3.3 bln to care providers hit by cyberattacks

UnitedHealth Group has paid out more than $3.3 billion to providers impacted by Change Healthcare cyberattack

UnitedHealth Group has paid more than $3 billion to providers following cyberattack

The U.S. State Department on Wednesday offered up to $10 million for information on the "Blackcat" ransomware gang who hit the UnitedHealth Group's tech unit and snarled insurance payments across America.

US offers $10 million bounty for info on 'Blackcat' hackers who hit UnitedHealth

LOS ANGELES, CA / ACCESSWIRE / March 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of UnitedHealth Group Incorporated ("UnitedHealth" or "the Company") (NYSE:UNH) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against UnitedHealth Group Incorporated and Encourages Investors with Losses to Contact the Firm

Booking Hlds

Estee Lauder

It is possible for retail investors to consistently beat the market by owning above-average blue chip dividend growth stocks. Hard work, research, and staying rational are key factors in outperforming the market. I highlight specific blue chip stocks, such as Booking Holdings, Zoetis, UnitedHealth Group, and Elevance Health, that have strong growth potential and attractive valuations.

You Don't Have To Take Excess Risk To Beat The Market

Amgen

Amazon

Salesforce

McDonald's

Microsoft

Dow Jones 40,000 is a milestone investors have eyed for years. But now a handful of stocks are posed to make it a reality.

Dow 40,000 Is Coming Any Day Now Thanks To 8 Stocks, Analysts Say

Change Healthcare will begin processing more than $14 billion in claims following last month's cyberattack.

UnitedHealth Tackles $14 Billion Claims Backlog From Cyberattack

JPMorgan Chase & Co

Newmont Mining

Veralto Corp

Exxon Mobil

It doesn't seem like it based on the mercurial valuations of certain innovators but a rotation away from technology could open doors for stocks hedge funds are buying. Basically, it may be time to consider following the money.

Hedge Funds Are Fleeing Tech: 7 Stocks They're Buying Instead

UnitedHealth Group said on Friday it expects several services related to handling medical claims by its unit Change Healthcare to gradually be online over the next few weeks following a hack last month.

UnitedHealth says several services for handling medical claims at unit Change will go online

UnitedHealth Group (UNH) remains well-poised for growth on the back of improved premiums, acquisitions and partnerships, an in-demand telehealth services suite and solid cash-generating abilities.

Compelling Reasons to Hold on to UnitedHealth Group (UNH) Stock

A cyberattack on UnitedHealth's (UNH) subsidiary, Change Healthcare, last month continues to impact its healthcare services. The HHS investigation will determine any breach of protected health data.

UnitedHealth (UNH) Faces Investigation Following Cyberattack

UnitedHealth Group has had double whammy headwinds over the past few weeks, with the regulatory probe and cyberattack triggering a drastic -10.3% loss of value at its worst. However, we believe that the stock is an even more attractive Buy now, as the discounted valuations and pullback offer expanded upside potential and dividend yields. At the same time, the consensus forward estimates remain optimistic, with UNH expected to sustain its profitable growth trend through FY2026.

UnitedHealth Group: Buy The Recent Pullback - Long-Term Tailwinds Remain Excellent

Automatic Data Processing

Apollo Global Management

Brookfield Asset Management

British American Tobacco

Joel Greenblatt's Magic formula is rules-based and focused on ROC - return on capital. The critical elements of Greenblatt's formula are quality, value, diversification, and annual rebalancing. The Zen Quality Portfolio utilizes these elements, combining ETFs and individual stocks, including those with very high ROC/PEG.

News for UnitedHealth Group Stock (UNH)